Glibenclamide therapy: pros and cons
The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibe...
Guardado en:
Autores principales: | Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/176cc5d7a32949878807dfda4fd62a37 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New indications for exenatide therapy of type 2 diabetes mellitus
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2010) -
The results of open observational trial DIAMOND
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2011) -
Treatment of DM2 to-day. Should we change priorities? Conclusions based on recent clinical studies
por: Aleksey Vadimovich Zilov
Publicado: (2009) -
Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry
por: Ivan Ivanovich Dedov, et al.
Publicado: (2017) -
Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
por: Olga Yuryevna Sukhareva, et al.
Publicado: (2016)